North American Prodromal Synucleinopathy Consortium Stage 2 | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
North American Prodromal Synucleinopathy Consortium Stage 2	Lewy body dementia, Parasomnias, Parkinson disease, REM Sleep Parasomnias, REM sleep behavior disorder, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, sleep-wake disorder, synucleinopathy	Enrolling by invitation	Not stated	2026-05-13		NCT05826457

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Emory University	393
Massachusetts General Hospital	758
Mayo Clinic	970
McGill University	81
National Institute of Neurological Disorders and Stroke (NINDS)	370
National Institute on Aging (NIA)	571
National Institutes of Health (NIH)	667
Oregon Health and Science University	244
Stanford University	620
University of California, Los Angeles	355
University of Minnesota	344
Washington University School of Medicine	475

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Emory University	Atlanta	United States	262
Massachusetts General Hospital	Boston	United States	3
Mayo Clinic Rochester	Rochester	United States	133
McGill University Health Centre Research Institute	Montreal	Canada	2
Oregon Health Sciences University	Portland	United States	33
Stanford University	Redwood City	United States	25
University of California Los Angeles	Los Angeles	United States	87
University of Minnesota	Minneapolis	United States	69
Washington University School of Medicine	St Louis	United States	895